Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis
- PMID: 20451685
- DOI: 10.1016/j.amjcard.2009.12.064
Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis
Abstract
Using serial volumetric intravascular ultrasonography, we evaluated the predictors of late intimal hyperplasia (IH) increases after drug-eluting stent implantation. All eligible patients who underwent 6-month angiography without visual restenosis were requested to undergo a 2-year follow-up examination. Complete serial (after stenting and early [6-month], and late [2-year] follow-up) angiographic and intravascular ultrasound data were available for 135 patients with 143 lesions: 99 sirolimus-eluting stents and 44 paclitaxel-eluting stents. The external elastic membrane, stent, lumen, and peri-stent plaque volumes (external elastic membrane minus stent) were normalized by stent length. The percentage of IH volume was calculated as IH volume/stent volume x 100. The early reduction in the minimum lumen area was greater than the late reduction in the minimum lumen area (-0.8 +/- 0.8 vs -0.2 +/- 0.5 mm(2), p <0.001). A progressive increase occurred in the percentage of IH volume: 8.1 +/- 7.1% from baseline to 6 months and 2.4 +/- 3.9% from 6 months to 2 years (p <0.001, between the early and late increases in the percentage of IH). The use of paclitaxel-eluting stents was the only independent predictor for the percentage of IH volume at 6 months (beta = 0.419, p <0.001). The use of paclitaxel-eluting stents (beta = 0.365, p <0.001, 95% confidence interval 3.7 to 9.7) and the post-stenting normalized plaque and media volume (beta = 0.195, p = 0.020, 95% confidence interval 0.1 to 1.6) were the only independent predictors for the percentage of IH volume at 2 years. However, when the percentage of IH at 6 months was forced into the model, the percentage of IH at 6 months and the post-stenting normalized plaque and media volume, not paclitaxel-eluting stent use, predicted the 2-year percentage of IH. In conclusion, although IH continued to increase beyond 6 months, the growth rate of intima and luminal loss attenuated with time.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.Circ Cardiovasc Interv. 2011 Apr 1;4(2):139-45. doi: 10.1161/CIRCINTERVENTIONS.110.957936. Epub 2011 Mar 1. Circ Cardiovasc Interv. 2011. PMID: 21364151 Clinical Trial.
-
Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.Cardiovasc Revasc Med. 2010 Jul-Sep;11(3):140-8. doi: 10.1016/j.carrev.2009.07.004. Cardiovasc Revasc Med. 2010. PMID: 20599163 Clinical Trial.
-
Late restenosis following sirolimus-eluting stent implantation.JACC Cardiovasc Interv. 2011 Jan;4(1):123-8. doi: 10.1016/j.jcin.2010.09.013. JACC Cardiovasc Interv. 2011. PMID: 21251639
-
Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound.Am J Cardiol. 2007 Oct 22;100(8B):26M-35M. doi: 10.1016/j.amjcard.2007.08.019. Am J Cardiol. 2007. PMID: 17950829 Review.
-
Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition.J Am Coll Cardiol. 2014 Apr 15;63(14):1355-67. doi: 10.1016/j.jacc.2014.01.019. Epub 2014 Feb 13. J Am Coll Cardiol. 2014. PMID: 24530675 Review.
Cited by
-
Temporal course of neointimal hyperplasia following drug-eluting stent implantation: a serial follow-up optical coherence tomography analysis.Int J Cardiovasc Imaging. 2014 Aug;30(6):1003-11. doi: 10.1007/s10554-014-0437-5. Epub 2014 May 8. Int J Cardiovasc Imaging. 2014. PMID: 24807243
-
Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.J Am Heart Assoc. 2017 Apr 14;6(4):e005386. doi: 10.1161/JAHA.116.005386. J Am Heart Assoc. 2017. PMID: 28411245 Free PMC article.
-
Tissue characteristics of neointima in late restenosis: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.Heart Vessels. 2017 May;32(5):531-538. doi: 10.1007/s00380-016-0903-1. Epub 2016 Oct 11. Heart Vessels. 2017. PMID: 27730297
-
Atherosclerotic plaque behind the stent changes after bare-metal and drug-eluting stent implantation in humans: Implications for late stent failure?Atherosclerosis. 2016 Sep;252:9-14. doi: 10.1016/j.atherosclerosis.2016.07.914. Epub 2016 Jul 22. Atherosclerosis. 2016. PMID: 27494445 Free PMC article.
-
Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics.Eur Heart J. 2013 Nov;34(42):3304-13. doi: 10.1093/eurheartj/eht241. Epub 2013 Jul 3. Eur Heart J. 2013. PMID: 23824827 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources